MetaPhore reports general anti-inflammatory surface treatment for biomedical materials

ST. LOUIS, June 27, 2000 -- The nearly 50,000 heart surgery patients who suffer severe problems after stents are inserted into their unclogged arteries are among the growing number Americans with medical implants who may benefit from a general anti-inflammatory surface treatment for biomedical materials reported for the first time today in the Journal of Biomedical Materials Research. Some estimates suggest that one in ten Americans may have a medical implant of some kind.

Researchers at MetaPhore Pharmaceuticals treated the surface of three commonly used device materials -- polyethylene, poly(etherurethane urea) and tantalum metal -- to allow permanent attachment of a new class of anti-inflammatory drugs, and then implanted the materials in a rat model. Examination of tissue surrounding the implant revealed a dose dependent anti-inflammatory effect, including:

  • A dramatic reduction in both acute and chronic inflammation around the materials,
  • A potent inhibitory effect on matrix production and fibrosis on the implant surface, and
  • A protective effect on poly(etherurethane urea) biodegradation in vivo

"These dramatic results are, to our knowledge, the first description of a general anti-inflammatory surface treatment for biomedical materials," said Kishore Udipi of Metaphore Pharmaceuticals. Other members of the research team included: Denis Forster and Dennis Riley, also of Metaphore Pharmaceuticals and Richard L. Ornberg, Bruce Thurmond and Steven Settle of Searle.

The new class of anti-inflammatory drugs simulates -- or mimics -- the natural enzyme superoxide dismutase (SOD), which combats superoxide ions secreted by white blood cells in the body in its efforts to break down a material implant. Unchecked, the secretion of superoxide ions, as well as digestive enzymes, results in the implant's degradation and loss of function as well as chronic inflammation and fibrotic capsule formation.

Superoxide is a free

Contact: Steve Littlejohn
Kupper Parker Communications

Page: 1 2

Related biology news :

1. APP reports Abraxane(TM) is active in breast cancer patients who failed taxol or taxotere
2. Scientists question reports of massive ant supercolonies in California and Europe
3. Survey reports fall in stem cell transplants for breast cancer
4. VaxGen reports Phase I clinical trial results of anthrax vaccine candidate
5. Immerge reports PERVs most infectious to human cells not part of germ-line DNA of mini-swine
6. By the year 2050, human population could add 2.6 billion people, reports Rockefeller scientist
7. Measles on the rise as vaccinations fall in the UK, Science study reports
8. WCS biologist George Schaller reports surprising increase in Tibets wildlife
9. Clinical study reports findings of combination therapy with DOXIL
10. Europes population has developed new tendency to shrink, Science study reports
11. U of A scientist finds Atlantic salmon escapes higher than government reports

Post Your Comments:

(Date:11/12/2019)... GREEN, Ohio (PRWEB) , ... ... ... Engineered Products , a global leader in the design and manufacturer of ... selection of seating and adjustable footrests compliant with Healthier Hospital Initiative guidelines. ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... microbial identification, played a key role in the award-winning study “Next Generation Sequencing ... Rothman Institute. The molecular diagnostic laboratory processed samples using Next Generation DNA Sequencing ...
(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... ... that Donald Stanski, MD, a senior pharmaceutical industry executive with expertise in clinical ... simulation for drug and disease strategic data analytics, has joined the firm as ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare , ... for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information from ... 2.0 will give urologists across Europe the ability to perform targeted transrectal and ...
(Date:11/2/2019)... NEW YORK (PRWEB) , ... October 31, 2019 ... ... just been released by pharma artificial intelligence pioneer tellic. drug360 brings tellic’s ... data. This new tool allows researchers to quickly uncover relationships between genes, diseases, ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, ... sponsorship and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, ... California. , The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge ...
(Date:10/22/2019)... N.J. (PRWEB) , ... October 22, 2019 , ... Catalent, ... Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session ... Conference (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019. ...
Breaking Biology Technology:
Cached News: